SEARCH RESULTS

5 RESULTS

Fuyuki Kametani on In Mice, Aducanumab Neutralizes Aβ Seeds

COMMENT Suppressing or slowing the progression of AD is thought to be a pathological condition shown in the reference paper. It has been shown that even if Aβ is deposited, disease onset can be suppressed or delayed by suppressing the spread of tau pathology. ...

Fuyuki Kametani on Presenilin Loss of Function—Plan B for AD?

COMMENT Shen and Kelleher offer a very interesting hypothesis. I have reported that AICDε (C50) is preferentially produced from the α-secretase product C83, not from C89 and C99, indicating that γ-site cleavage and ε-site cleavage are regulated differently (Kume ...

Current Filters

  • TYPE: Comment x
  • Commentator: Kametani, Fuyuki x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE